Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

E. Klyuchnikov, U. Bacher, K. Woo Ahn, J. Carreras, N. M. Kröger, P. N. Hari, G. H. Ku, E. Ayala, A. I. Chen, Y. B. Chen, J. B. Cohen, C. O. Freytes, R. P. Gale, R. T. Kamble, M. A. Kharfan-Dabaja, H. M. Lazarus, R. Martino, A. Mussetti, B. N. Savani, H. C. Schouten & 6 others S. Z. Usmani, P. H. Wiernik, B. Wirk, S. M. Smith, A. Sureda, M. Hamadani

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-term outcomes after allogeneic (allo-) vs autologous hematopoietic cell transplantation (auto-HCT) in the rituximab era. A total of 197 patients undergoing first reduced-intensity conditioning (RIC) allo-HCT or first auto-HCT during 2000-2012 were included. Rituximab-naive patients were excluded. Allo-HCT recipients were younger, more heavily pretreated and had a longer interval between diagnosis and HCT. The 5-year probabilities of non-relapse mortality (NRM), relapse/progression, PFS and overall survival (OS) for auto-HCT vs allo-HCT groups were 4% vs 27% (P

Original languageEnglish
Pages (from-to)58-66
Number of pages9
JournalBone Marrow Transplantation
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Follicular Lymphoma
Autologous Transplantation
Cell Transplantation
Homologous Transplantation
Survival
Transplantation
Recurrence
Mortality
Rituximab

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Klyuchnikov, E., Bacher, U., Woo Ahn, K., Carreras, J., Kröger, N. M., Hari, P. N., ... Hamadani, M. (2016). Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Bone Marrow Transplantation, 51(1), 58-66. https://doi.org/10.1038/bmt.2015.223

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. / Klyuchnikov, E.; Bacher, U.; Woo Ahn, K.; Carreras, J.; Kröger, N. M.; Hari, P. N.; Ku, G. H.; Ayala, E.; Chen, A. I.; Chen, Y. B.; Cohen, J. B.; Freytes, C. O.; Gale, R. P.; Kamble, R. T.; Kharfan-Dabaja, M. A.; Lazarus, H. M.; Martino, R.; Mussetti, A.; Savani, B. N.; Schouten, H. C.; Usmani, S. Z.; Wiernik, P. H.; Wirk, B.; Smith, S. M.; Sureda, A.; Hamadani, M.

In: Bone Marrow Transplantation, Vol. 51, No. 1, 01.01.2016, p. 58-66.

Research output: Contribution to journalArticle

Klyuchnikov, E, Bacher, U, Woo Ahn, K, Carreras, J, Kröger, NM, Hari, PN, Ku, GH, Ayala, E, Chen, AI, Chen, YB, Cohen, JB, Freytes, CO, Gale, RP, Kamble, RT, Kharfan-Dabaja, MA, Lazarus, HM, Martino, R, Mussetti, A, Savani, BN, Schouten, HC, Usmani, SZ, Wiernik, PH, Wirk, B, Smith, SM, Sureda, A & Hamadani, M 2016, 'Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma', Bone Marrow Transplantation, vol. 51, no. 1, pp. 58-66. https://doi.org/10.1038/bmt.2015.223
Klyuchnikov, E. ; Bacher, U. ; Woo Ahn, K. ; Carreras, J. ; Kröger, N. M. ; Hari, P. N. ; Ku, G. H. ; Ayala, E. ; Chen, A. I. ; Chen, Y. B. ; Cohen, J. B. ; Freytes, C. O. ; Gale, R. P. ; Kamble, R. T. ; Kharfan-Dabaja, M. A. ; Lazarus, H. M. ; Martino, R. ; Mussetti, A. ; Savani, B. N. ; Schouten, H. C. ; Usmani, S. Z. ; Wiernik, P. H. ; Wirk, B. ; Smith, S. M. ; Sureda, A. ; Hamadani, M. / Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. In: Bone Marrow Transplantation. 2016 ; Vol. 51, No. 1. pp. 58-66.
@article{16b84794db5442aba417adf816eefc69,
title = "Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma",
abstract = "Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-term outcomes after allogeneic (allo-) vs autologous hematopoietic cell transplantation (auto-HCT) in the rituximab era. A total of 197 patients undergoing first reduced-intensity conditioning (RIC) allo-HCT or first auto-HCT during 2000-2012 were included. Rituximab-naive patients were excluded. Allo-HCT recipients were younger, more heavily pretreated and had a longer interval between diagnosis and HCT. The 5-year probabilities of non-relapse mortality (NRM), relapse/progression, PFS and overall survival (OS) for auto-HCT vs allo-HCT groups were 4{\%} vs 27{\%} (P",
author = "E. Klyuchnikov and U. Bacher and {Woo Ahn}, K. and J. Carreras and Kr{\"o}ger, {N. M.} and Hari, {P. N.} and Ku, {G. H.} and E. Ayala and Chen, {A. I.} and Chen, {Y. B.} and Cohen, {J. B.} and Freytes, {C. O.} and Gale, {R. P.} and Kamble, {R. T.} and Kharfan-Dabaja, {M. A.} and Lazarus, {H. M.} and R. Martino and A. Mussetti and Savani, {B. N.} and Schouten, {H. C.} and Usmani, {S. Z.} and Wiernik, {P. H.} and B. Wirk and Smith, {S. M.} and A. Sureda and M. Hamadani",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/bmt.2015.223",
language = "English",
volume = "51",
pages = "58--66",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

AU - Klyuchnikov, E.

AU - Bacher, U.

AU - Woo Ahn, K.

AU - Carreras, J.

AU - Kröger, N. M.

AU - Hari, P. N.

AU - Ku, G. H.

AU - Ayala, E.

AU - Chen, A. I.

AU - Chen, Y. B.

AU - Cohen, J. B.

AU - Freytes, C. O.

AU - Gale, R. P.

AU - Kamble, R. T.

AU - Kharfan-Dabaja, M. A.

AU - Lazarus, H. M.

AU - Martino, R.

AU - Mussetti, A.

AU - Savani, B. N.

AU - Schouten, H. C.

AU - Usmani, S. Z.

AU - Wiernik, P. H.

AU - Wirk, B.

AU - Smith, S. M.

AU - Sureda, A.

AU - Hamadani, M.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-term outcomes after allogeneic (allo-) vs autologous hematopoietic cell transplantation (auto-HCT) in the rituximab era. A total of 197 patients undergoing first reduced-intensity conditioning (RIC) allo-HCT or first auto-HCT during 2000-2012 were included. Rituximab-naive patients were excluded. Allo-HCT recipients were younger, more heavily pretreated and had a longer interval between diagnosis and HCT. The 5-year probabilities of non-relapse mortality (NRM), relapse/progression, PFS and overall survival (OS) for auto-HCT vs allo-HCT groups were 4% vs 27% (P

AB - Grade 3 follicular lymphoma (FL) has aggressive clinical behavior. To evaluate the optimal first transplantation approach in relapsed/refractory grade 3 FL patients, we compared the long-term outcomes after allogeneic (allo-) vs autologous hematopoietic cell transplantation (auto-HCT) in the rituximab era. A total of 197 patients undergoing first reduced-intensity conditioning (RIC) allo-HCT or first auto-HCT during 2000-2012 were included. Rituximab-naive patients were excluded. Allo-HCT recipients were younger, more heavily pretreated and had a longer interval between diagnosis and HCT. The 5-year probabilities of non-relapse mortality (NRM), relapse/progression, PFS and overall survival (OS) for auto-HCT vs allo-HCT groups were 4% vs 27% (P

UR - http://www.scopus.com/inward/record.url?scp=84953367337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953367337&partnerID=8YFLogxK

U2 - 10.1038/bmt.2015.223

DO - 10.1038/bmt.2015.223

M3 - Article

VL - 51

SP - 58

EP - 66

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -